Skye Bioscience (SKYE) Reiterated at Market Outperform by Citizens on Nimacimab Data

Go back to Skye Bioscience (SKYE) Reiterated at Market Outperform by Citizens on Nimacimab Data
(NASDAQ: SKYE) Delayed: 0.77 +0.06 (8.45%)
Previous Close $0.71    52 Week High
Open $0.72    52 Week Low
Day High $0.78    P/E N/A 
Day Low $0.72    EPS
Volume 168,680